Attached files

file filename
EX-10.18 - EX-10.18 - PMV Pharmaceuticals, Inc.d922470dex1018.htm
EX-10.17 - EX-10.17 - PMV Pharmaceuticals, Inc.d922470dex1017.htm
EX-10.16 - EX-10.16 - PMV Pharmaceuticals, Inc.d922470dex1016.htm
EX-10.15 - EX-10.15 - PMV Pharmaceuticals, Inc.d922470dex1015.htm
EX-10.14 - EX-10.14 - PMV Pharmaceuticals, Inc.d922470dex1014.htm
EX-10.13 - EX-10.13 - PMV Pharmaceuticals, Inc.d922470dex1013.htm
EX-10.12 - EX-10.12 - PMV Pharmaceuticals, Inc.d922470dex1012.htm
EX-10.11 - EX-10.11 - PMV Pharmaceuticals, Inc.d922470dex1011.htm
EX-10.10 - EX-10.10 - PMV Pharmaceuticals, Inc.d922470dex1010.htm
EX-10.9 - EX-10.9 - PMV Pharmaceuticals, Inc.d922470dex109.htm
EX-10.8 - EX-10.8 - PMV Pharmaceuticals, Inc.d922470dex108.htm
EX-10.7 - EX-10.7 - PMV Pharmaceuticals, Inc.d922470dex107.htm
EX-10.6 - EX-10.6 - PMV Pharmaceuticals, Inc.d922470dex106.htm
EX-10.5 - EX-10.5 - PMV Pharmaceuticals, Inc.d922470dex105.htm
EX-10.4 - EX-10.4 - PMV Pharmaceuticals, Inc.d922470dex104.htm
EX-10.3 - EX-10.3 - PMV Pharmaceuticals, Inc.d922470dex103.htm
EX-10.2 - EX-10.2 - PMV Pharmaceuticals, Inc.d922470dex102.htm
EX-10.1 - EX-10.1 - PMV Pharmaceuticals, Inc.d922470dex101.htm
EX-4.1 - EX-4.1 - PMV Pharmaceuticals, Inc.d922470dex41.htm
EX-3.4 - EX-3.4 - PMV Pharmaceuticals, Inc.d922470dex34.htm
EX-3.3 - EX-3.3 - PMV Pharmaceuticals, Inc.d922470dex33.htm
EX-3.2 - EX-3.2 - PMV Pharmaceuticals, Inc.d922470dex32.htm
EX-3.1 - EX-3.1 - PMV Pharmaceuticals, Inc.d922470dex31.htm
S-1 - S-1 - PMV Pharmaceuticals, Inc.d922470ds1.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 26, 2020 in the Registration Statement (Form S-1) and related Prospectus of PMV Pharmaceuticals, Inc. for the registration of shares of its common stock.

/s/ Ernst & Young LLP

Philadelphia, Pennsylvania

September 4, 2020